Invesaro

Stocks Comparison

Criteo vs Haoxi Health Technology: revenue, profit, margins and growth compared

Criteo brought in $1.9B of revenue in fiscal 2025, Haoxi Health Technology $54.8M in fiscal 2026. Revenue changed by +0.6% at Criteo and +67.1% at Haoxi Health Technology on the year before, so Haoxi Health Technology grew faster. Criteo kept 7.4% of its revenue as net profit, Haoxi Health Technology -17.4%.

Side by side, latest fiscal year

CRTOHAO
Fiscal year endedFY2025 (December 31, 2025)FY2026 (June 30, 2026)
Revenue$1.9B$54.8M
Revenue growth+0.6%+67.1%
Net income$144.6M-$9.5M
Net margin7.4%-17.4%
Free cash flow$208.5Mn/a
Free cash flow margin10.7%n/a
Earnings per share (diluted)$2.64-$386.40
Cash$342M$10.9M
Debtn/a$290.7K
Price to earnings6.4n/a
Market value$831.7M$679.2K
Dividend yieldn/an/a
Rank by revenue in sector#374 of 1077 · Consumer discretionary#805 of 1077 · Consumer discretionary

Over the years

Revenue
CRTO FY2018: $2.3BCRTO FY2019: $2.3BCRTO FY2020: $2.1BCRTO FY2021: $2.3BCRTO FY2022: $2BCRTO FY2023: $1.9BCRTO FY2024: $1.9BCRTO FY2025: $1.9BHAO FY2022: $16.2MHAO FY2024: $28.2MHAO FY2024: $48.5MHAO FY2025: $32.8MHAO FY2026: $54.8MFY18FY19FY20FY21FY22FY23FY24FY25FY26
CRTO $1.9BHAO $54.8M
Net income
CRTO FY2018: $88.6MCRTO FY2019: $90.7MCRTO FY2020: $71.7MCRTO FY2021: $134.5MCRTO FY2022: $9MCRTO FY2023: $53.3MCRTO FY2024: $111.6MCRTO FY2025: $144.6MHAO FY2022: $244.6KHAO FY2024: $969.8KHAO FY2024: $1.3MHAO FY2025: $3.9MHAO FY2026: -$9.5MFY18FY19FY20FY21FY22FY23FY24FY25FY26
CRTO $144.6MHAO -$9.5M
Net margin
CRTO FY2018: 3.9%CRTO FY2019: 4.0%CRTO FY2020: 3.5%CRTO FY2021: 6.0%CRTO FY2022: 0.4%CRTO FY2023: 2.7%CRTO FY2024: 5.8%CRTO FY2025: 7.4%HAO FY2022: 1.5%HAO FY2024: 3.4%HAO FY2024: 2.7%HAO FY2025: 11.8%HAO FY2026: -17.4%FY18FY19FY20FY21FY22FY23FY24FY25FY26
CRTO 7.4%HAO -17.4%
Revenue growth
CRTO FY2019: -1.7%CRTO FY2020: -8.4%CRTO FY2021: +8.8%CRTO FY2022: -10.5%CRTO FY2023: -3.3%CRTO FY2024: -0.8%CRTO FY2025: +0.6%HAO FY2024: +74.7%HAO FY2024: +71.9%HAO FY2025: -32.4%HAO FY2026: +67.1%FY19FY20FY21FY22FY23FY24FY25FY26
CRTO +0.6%HAO +67.1%
Free cash flow
CRTO FY2022: $192.2MCRTO FY2023: $108.1MCRTO FY2024: $180MCRTO FY2025: $208.5MHAO FY2022: -$684.1KHAO FY2024: -$917.6KHAO FY2024: -$802.9KFY22FY23FY24FY25
CRTO $208.5MHAO -$802.9K

Fiscal years as each company reports them; the two may end in different months.

Questions about Criteo and Haoxi Health Technology

Which is bigger by revenue, Criteo or Haoxi Health Technology?

Criteo is bigger by revenue: $1.9B in fiscal 2025, against $54.8M for Haoxi Health Technology in fiscal 2026.

Which keeps more of its revenue as profit, Criteo or Haoxi Health Technology?

Criteo had a net margin of 7.4% in fiscal 2025; Haoxi Health Technology had -17.4% in fiscal 2026.

Which grew revenue faster, Criteo or Haoxi Health Technology?

In their latest fiscal years revenue changed by +0.6% at Criteo and +67.1% at Haoxi Health Technology.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies